218 related articles for article (PubMed ID: 7807699)
1. [Effectiveness of oral treatment with terbinafine in a guinea pig model of tinea pedis].
Uchida K; Yamaguchi H
Jpn J Antibiot; 1994 Oct; 47(10):1401-6. PubMed ID: 7807699
[TBL] [Abstract][Full Text] [Related]
2. [A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
Uchida K; Kudoh M; Yamaguchi H
Jpn J Antibiot; 1994 Oct; 47(10):1407-12. PubMed ID: 7807700
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
Tatsumi Y; Yokoo M; Senda H; Kakehi K
Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
[TBL] [Abstract][Full Text] [Related]
4. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis.
Uchida K; Tanaka T; Yamaguchi H
Microbiol Immunol; 2003; 47(2):143-6. PubMed ID: 12680717
[TBL] [Abstract][Full Text] [Related]
5. [Seven days of intermittent terbinafine 250 mg treatment in Tinea pedis].
Hamaguchi T; Takiuchi I
Nihon Ishinkin Gakkai Zasshi; 2002; 43(2):79-83. PubMed ID: 12040364
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of AS2077715 against experimental tinea pedis in guinea pigs in comparison with terbinafine.
Ohsumi K; Murai H; Nakamura I; Watanabe M; Fujie A
J Antibiot (Tokyo); 2014 Oct; 67(10):717-9. PubMed ID: 24865864
[TBL] [Abstract][Full Text] [Related]
7. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis.
Kikuchi I; Tanuma H; Morimoto K; Kawana S
Mycoses; 2008 Jan; 51(1):7-13. PubMed ID: 18076589
[TBL] [Abstract][Full Text] [Related]
8. [Prophylactic effect of oral terbinafine on the development of infection in guinea pigs inoculated with Trichophyton mentagrophytes].
Uchida K; Yamaguchi H
Jpn J Antibiot; 1994 Jan; 47(1):50-6. PubMed ID: 8114273
[TBL] [Abstract][Full Text] [Related]
9. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
Kikuchi I; Tanuma H; Morimoto K; Kawana S
Mycoses; 2008 Nov; 51(6):523-31. PubMed ID: 18422915
[TBL] [Abstract][Full Text] [Related]
10. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.
Savin RC
J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):807-9. PubMed ID: 2229529
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antifungal efficacy in an optimized animal model of Trichophyton mentagrophytes-dermatophytosis.
Ghannoum MA; Hossain MA; Long L; Mohamed S; Reyes G; Mukherjee PK
J Chemother; 2004 Apr; 16(2):139-44. PubMed ID: 15216947
[TBL] [Abstract][Full Text] [Related]
12. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
Shi TW; Zhang JA; Zhang XW; Yu HX; Tang YB; Yu JB
Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis.
Takiuchi I; Morishita N; Hamaguchi T; Ninomiya J; Higuchi R
Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):285-9. PubMed ID: 16282972
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
[TBL] [Abstract][Full Text] [Related]
16. In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Microbiol Immunol; 2002; 46(7):433-9. PubMed ID: 12222929
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of omoconazole nitrate on experimental tinea pedis, an intractable dermatophytosis, in guinea-pigs.
Itoyama T; Uchida K; Yamaguchi H; Fujita S
J Antimicrob Chemother; 1997 Sep; 40(3):441-4. PubMed ID: 9338501
[TBL] [Abstract][Full Text] [Related]
18. Comparison of one week of oral terbinafine (250 mg/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis.
Barnetson RS; Marley J; Bullen M; Brookman S; Cowen P; Ellis D; Williams T
Br J Dermatol; 1998 Oct; 139(4):675-8. PubMed ID: 9892913
[TBL] [Abstract][Full Text] [Related]
19. Anti-dermatophytic activity of bakuchiol: in vitro mechanistic studies and in vivo tinea pedis-inhibiting activity in a guinea pig model.
Lau KM; Wong JH; Wu YO; Cheng L; Wong CW; To MH; Lau CP; Yew DT; Leung PC; Fung KP; Hui M; Ng TB; Lau CB
Phytomedicine; 2014 Jun; 21(7):942-5. PubMed ID: 24703327
[TBL] [Abstract][Full Text] [Related]
20. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
Korting HC; Kiencke P; Nelles S; Rychlik R
Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
